• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习在抗癌药物敏感性预测中的最新进展与局限。

Current Advances and Limitations of Deep Learning in Anticancer Drug Sensitivity Prediction.

机构信息

School of Information Science and Technology, Northeast Normal University, Changchun 130117, China.

College of Humanities and Sciences of Northeast Normal University, Changchun 130117, China.

出版信息

Curr Top Med Chem. 2020;20(21):1858-1867. doi: 10.2174/1568026620666200710101307.

DOI:10.2174/1568026620666200710101307
PMID:32648840
Abstract

Anticancer drug screening can accelerate drug discovery to save the lives of cancer patients, but cancer heterogeneity makes this screening challenging. The prediction of anticancer drug sensitivity is useful for anticancer drug development and the identification of biomarkers of drug sensitivity. Deep learning, as a branch of machine learning, is an important aspect of in silico research. Its outstanding computational performance means that it has been used for many biomedical purposes, such as medical image interpretation, biological sequence analysis, and drug discovery. Several studies have predicted anticancer drug sensitivity based on deep learning algorithms. The field of deep learning has made progress regarding model performance and multi-omics data integration. However, deep learning is limited by the number of studies performed and data sources available, so it is not perfect as a pre-clinical approach for use in the anticancer drug screening process. Improving the performance of deep learning models is a pressing issue for researchers. In this review, we introduce the research of anticancer drug sensitivity prediction and the use of deep learning in this research area. To provide a reference for future research, we also review some common data sources and machine learning methods. Lastly, we discuss the advantages and disadvantages of deep learning, as well as the limitations and future perspectives regarding this approach.

摘要

抗癌药物筛选可以加速药物发现,挽救癌症患者的生命,但癌症异质性使得这种筛选具有挑战性。抗癌药物敏感性预测对于抗癌药物开发和药物敏感性生物标志物的识别很有用。深度学习作为机器学习的一个分支,是计算机研究的一个重要方面。其出色的计算性能意味着它已被用于许多生物医学用途,如医学图像解释、生物序列分析和药物发现。已有几项研究基于深度学习算法预测了抗癌药物的敏感性。在模型性能和多组学数据集成方面,深度学习领域已经取得了进展。然而,深度学习受到研究数量和可用数据源的限制,因此作为癌症药物筛选过程中的临床前方法并不完美。提高深度学习模型的性能是研究人员面临的紧迫问题。在这篇综述中,我们介绍了抗癌药物敏感性预测的研究以及深度学习在这一研究领域的应用。为未来的研究提供参考,我们还回顾了一些常见的数据源和机器学习方法。最后,我们讨论了深度学习的优缺点,以及该方法的局限性和未来展望。

相似文献

1
Current Advances and Limitations of Deep Learning in Anticancer Drug Sensitivity Prediction.深度学习在抗癌药物敏感性预测中的最新进展与局限。
Curr Top Med Chem. 2020;20(21):1858-1867. doi: 10.2174/1568026620666200710101307.
2
DeepCancerMap: A versatile deep learning platform for target- and cell-based anticancer drug discovery.深癌图谱:一个用于基于靶点和细胞的抗癌药物发现的多功能深度学习平台。
Eur J Med Chem. 2023 Jul 5;255:115401. doi: 10.1016/j.ejmech.2023.115401. Epub 2023 Apr 23.
3
A systematic literature review for the prediction of anticancer drug response using various machine-learning and deep-learning techniques.一项使用各种机器学习和深度学习技术预测抗癌药物反应的系统文献综述。
Chem Biol Drug Des. 2023 Jan;101(1):175-194. doi: 10.1111/cbdd.14164. Epub 2022 Nov 10.
4
Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.利用机器学习进展进行药物发现和分子生物学中的数据整合
Methods Mol Biol. 2021;2190:167-184. doi: 10.1007/978-1-0716-0826-5_7.
5
Recent Advances in Drug Discovery and Cancer Diagnoses.药物发现和癌症诊断的最新进展。
Curr Top Med Chem. 2020;20(21):1855-1857. doi: 10.2174/156802662021200817164143.
6
DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.DeepDRK:一种基于核的多组学整合的药物重定位深度学习框架。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab048.
7
Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.利用深度学习指导的可解释模型预测抗癌药物敏感性。
BMC Bioinformatics. 2024 May 9;25(1):182. doi: 10.1186/s12859-024-05669-x.
8
Anticancer peptides prediction with deep representation learning features.基于深度表示学习特征的抗癌肽预测。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab008.
9
TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.TranSynergy:用于药物组合协同预测和途径解卷积的基于机制的可解释深度神经网络。
PLoS Comput Biol. 2021 Feb 12;17(2):e1008653. doi: 10.1371/journal.pcbi.1008653. eCollection 2021 Feb.
10
Application of Machine Learning Approaches for the Design and Study of Anticancer Drugs.机器学习方法在抗癌药物设计与研究中的应用。
Curr Drug Targets. 2019;20(5):488-500. doi: 10.2174/1389450119666180809122244.

引用本文的文献

1
G-: Knowledge graph neural network for structure-free protein-ligand bioactivity prediction.G-:用于无结构蛋白质-配体生物活性预测的知识图谱神经网络。
Comput Struct Biotechnol J. 2024 Jul 6;23:2872-2882. doi: 10.1016/j.csbj.2024.06.029. eCollection 2024 Dec.
2
Challenges and advances in the management of inflammation in atherosclerosis.动脉粥样硬化炎症管理中的挑战与进展
J Adv Res. 2025 May;71:317-335. doi: 10.1016/j.jare.2024.06.016. Epub 2024 Jun 22.
3
Cancer detection and classification using a simplified binary state vector machine.
使用简化的二进制状态向量机进行癌症检测和分类。
Med Biol Eng Comput. 2024 May;62(5):1491-1501. doi: 10.1007/s11517-023-03012-9. Epub 2024 Feb 1.
4
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research.器官芯片在癌症建模研究中的最新进展。
Biosensors (Basel). 2022 Nov 18;12(11):1045. doi: 10.3390/bios12111045.
5
Deep learning prediction of chemical-induced dose-dependent and context-specific multiplex phenotype responses and its application to personalized alzheimer's disease drug repurposing.深度学习预测化学诱导的剂量依赖性和上下文特异性多重表型反应及其在个性化阿尔茨海默病药物再利用中的应用。
PLoS Comput Biol. 2022 Aug 11;18(8):e1010367. doi: 10.1371/journal.pcbi.1010367. eCollection 2022 Aug.